Sun Pharmaceutical Industries Ltd (SUNPHARMA) — Announcement | 25 September 2026
Sun Pharmaceutical announces that its trading window will close on 1 October 2026 and remain shut until 48 hours after the unaudited quarterly results for September 2026 are released, with the board meeting date to be set later.
About Sun Pharmaceutical Industries Ltd (SUNPHARMA)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when SUNPHARMA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SUNPHARMA — Free💡 Ask AI about this filing
📊 More SUNPHARMA filings
- 🔴 Announcement — 28 September 2026Sun Pharma announced a global licensing deal with LIB Therapeutics for lerodalcibep, a PCSK9 inhibit...
- 🟡 Voting Results — 28 September 2026Sun Pharmaceutical Industries announced the completion of its postal ballot dated 25 August 2026, co...
- 🟡 Shareholding Pattern — 26 September 2026Sun Pharmaceutical Industries announced that shareholders approved reclassifying the promoter group ...
- 🔴 Announcement — 22 September 2026Sun Pharmaceutical Industries Limited presented its investor outlook for FY26, highlighting a divers...
- 🔴 Announcement — 11 September 2026Sun Pharmaceutical announced a confidential settlement with a plaintiff in the In re Generic Pharmac...
🔥 Also filed on 25 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when SUNPHARMA files new disclosures
Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SUNPHARMA — FreeFree account · 2 AI queries/day